‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks

Martin Shkreli, a former hedge-fund manager known as “Pharma Bro,” is back in the crosshairs of U.S. regulators for influencing biopharma stocks even though he is banned from…

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketwatch.com)